RSMDF
ResMed Inc.
Price Chart
Latest Quote
$16.99
+0.00 (+0.00%)
Current Price
| Previous Close | $16.99 |
| Open | $20.06 |
| Day High | $20.06 |
| Day Low | $20.06 |
| Volume | 13 |
Stock Information
| Quarterly Dividend / Yield | $0.24 / 1.41% |
| Shares Outstanding | 1.45B |
| Quarterly Dividend Yield | 1.41% |
| Quarterly Dividend | $0.24 |
| Total Debt | $843.17M |
| Cash Equivalents | $1.66B |
| Revenue | $5.54B |
| Net Income | $1.52B |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $24.65B |
| P/E Ratio | 16.34 |
| EPS (TTM) | $1.04 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $9.04B |
| Sales | $5.54B |
| Income | $1.52B |
| Book/sh | $11.19 |
| Cash/sh | $1.14 |
| Employees | 11K |
Financial Ratios
| Quick Ratio | 2.00 |
| Current Ratio | 3.01 |
| Debt/Eq | 12.99 |
| EPS Growth TTM | 9.20% |
Returns & Margins
| ROA | 14.71% |
| ROE | 25.25% |
| Gross Margin | 62.18% |
| Operating Margin | 35.33% |
| Profit Margin | 27.44% |
Ownership
| Institutional Ownership | 8.50% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 41.44 |
| PEG | 1.00 |
| P/S | 4.45 |
| P/B | 1.52 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $17.64 |
| SMA50 | $20.48 |
| SMA200 | $23.96 |
| ATR | 0.0671 |
| Shares Float | 576.64M |
| Volatility | 0.78 |
Performance History
| Week | +0.00% |
| Month | -10.50% |
| Quarter | -33.49% |
| 6 Months | -37.21% |
| YTD | -35.99% |
| Year | -21.76% |
| 3 Years | -18.93% |
| 5 Years | -16.64% |
| 10 Years | +210.28% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-15 | $16.99 | 0 |
| 2026-06-12 | $16.99 | 0 |
| 2026-06-11 | $16.99 | 0 |
| 2026-06-10 | $16.99 | 0 |
| 2026-06-09 | $16.99 | 0 |
| 2026-06-08 | $16.99 | 325 |
| 2026-06-05 | $17.93 | 0 |
| 2026-06-04 | $17.93 | 0 |
| 2026-06-03 | $17.93 | 0 |
| 2026-06-02 | $17.93 | 0 |
| 2026-06-01 | $17.93 | 0 |
| 2026-05-29 | $17.93 | 0 |
| 2026-05-28 | $17.93 | 0 |
| 2026-05-27 | $17.93 | 0 |
| 2026-05-26 | $17.93 | 0 |
| 2026-05-22 | $17.93 | 0 |
| 2026-05-21 | $17.93 | 0 |
| 2026-05-20 | $17.93 | 0 |
| 2026-05-19 | $17.93 | 156 |
| 2026-05-18 | $17.72 | 239 |
About ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
đ° Latest News
ResMed (RMD) Stock Valuation Check After Mixed Returns And Undervaluation Signals
Simply Wall St. âĸ 2026-06-15T04:17:58Z
Is ResMed Inc. (RMD) A Good Stock To Buy Now?
Insider Monkey âĸ 2026-06-11T15:25:28Z
Is This the Right Time to Retain Resmed Stock in Your Portfolio?
Zacks âĸ 2026-06-09T12:55:00Z
ResMed (RMD) Acquires Noctrix Health to Expand Sleep Disorder Portfolio
Insider Monkey âĸ 2026-06-05T21:24:40Z
ResMed completes $340m Noctrix Health acquisition
Medical Device Network âĸ 2026-06-04T11:17:33Z
3 Big Reasons RMD Should Be On Your Watchlist
StockStory âĸ 2026-06-03T17:43:33Z
Is It Time To Reassess ResMed (RMD) After A 25% Share Price Slide?
Simply Wall St. âĸ 2026-06-03T12:14:11Z
Resmed completes $340M Noctrix takeover
MedTech Dive âĸ 2026-06-02T06:30:50Z
Do Wall Street Analysts Like ResMed Stock?
Barchart âĸ 2026-05-25T10:35:15Z
2 Healthcare Stocks to Research Further and 1 We Find Risky
StockStory âĸ 2026-05-23T11:08:55Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,900,819,000 | $1,860,306,000 | $1,711,789,000 | $1,391,053,000 |
| Cost Of Revenue | $2,091,357,000 | $2,029,994,000 | $1,867,331,000 | $1,553,816,000 |
| Total Revenue | $5,146,327,000 | $4,685,297,000 | $4,222,993,000 | $3,578,127,000 |
| Operating Revenue | $5,146,327,000 | $4,685,297,000 | $4,222,993,000 | $3,578,127,000 |
| Expenses | ||||
| Total Expenses | $3,458,933,000 | $3,301,176,000 | $3,070,996,000 | $2,575,977,000 |
| Other Income Expense | $-13,942,000 | $-73,615,000 | $-2,954,000 | $-19,355,000 |
| Other Non Operating Income Expenses | $-5,256,000 | $-3,494,000 | $-5,712,000 | $3,197,000 |
| Net Non Operating Interest Income Expense | $4,114,000 | $-45,708,000 | $-47,379,000 | $-22,312,000 |
| Total Other Finance Cost | $-4,114,000 | $45,708,000 | $47,379,000 | $22,312,000 |
| Operating Expense | $1,367,576,000 | $1,271,182,000 | $1,203,665,000 | $1,022,161,000 |
| Interest Expense | - | $45,708,000 | $47,379,000 | $22,312,000 |
| Interest Expense Non Operating | - | $45,708,000 | $47,379,000 | $22,312,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $1,400,723,000 | $1,020,951,000 | $897,556,000 | $779,437,000 |
| Net Interest Income | $4,114,000 | $-45,708,000 | $-47,379,000 | $-22,312,000 |
| Normalized Income | $1,402,418,885 | $1,072,782,996 | $897,473,713 | $780,950,568 |
| Net Income From Continuing And Discontinued Operation | $1,400,723,000 | $1,020,951,000 | $897,556,000 | $779,437,000 |
| Total Operating Income As Reported | $1,685,363,000 | $1,319,893,000 | $1,131,871,000 | $1,000,286,000 |
| Net Income Common Stockholders | $1,400,723,000 | $1,020,951,000 | $897,556,000 | $779,437,000 |
| Net Income | $1,400,723,000 | $1,020,951,000 | $897,556,000 | $779,437,000 |
| Net Income Including Noncontrolling Interests | $1,400,723,000 | $1,020,951,000 | $897,556,000 | $779,437,000 |
| Net Income Continuous Operations | $1,400,723,000 | $1,020,951,000 | $897,556,000 | $779,437,000 |
| Pretax Income | $1,677,566,000 | $1,264,798,000 | $1,101,664,000 | $960,483,000 |
| Special Income Charges | $-2,031,000 | $-64,228,000 | $101,000 | $-1,864,000 |
| Earnings From Equity Interest | $-6,655,000 | $-5,893,000 | $2,657,000 | $-20,688,000 |
| Operating Income | $1,687,394,000 | $1,384,121,000 | $1,151,997,000 | $1,002,150,000 |
| Depreciation Amortization Depletion Income Statement | $45,273,000 | $46,521,000 | $42,020,000 | $31,078,000 |
| Depreciation And Amortization In Income Statement | $45,273,000 | $46,521,000 | $42,020,000 | $31,078,000 |
| Amortization Of Intangibles Income Statement | $45,273,000 | $46,521,000 | $42,020,000 | $31,078,000 |
| Gross Profit | $3,054,970,000 | $2,655,303,000 | $2,355,662,000 | $2,024,311,000 |
| Interest Income | - | - | - | - |
| Interest Income Non Operating | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $0.95 | $0.69 | $0.61 | $0.53 |
| Basic EPS | $0.95 | $0.69 | $0.61 | $0.53 |
| Other | ||||
| Tax Effect Of Unusual Items | $-335,115 | $-12,396,004 | $18,713 | $-350,432 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,925,236,000 | $1,664,558,000 | $1,349,458,000 | $1,178,500,000 |
| Total Unusual Items | $-2,031,000 | $-64,228,000 | $101,000 | $-1,864,000 |
| Total Unusual Items Excluding Goodwill | $-2,031,000 | $-64,228,000 | $101,000 | $-1,864,000 |
| Reconciled Depreciation | $235,811,000 | $216,209,000 | $197,562,000 | $193,841,000 |
| EBITDA (Bullshit earnings) | $1,923,205,000 | $1,600,330,000 | $1,349,559,000 | $1,176,636,000 |
| EBIT | $1,687,394,000 | $1,384,121,000 | $1,151,997,000 | $982,795,000 |
| Diluted Average Shares | $1,473,400,000 | $1,475,500,000 | $1,474,550,000 | $1,470,430,000 |
| Basic Average Shares | $1,467,160,000 | $1,470,210,000 | $1,467,650,000 | $1,460,660,000 |
| Diluted NI Availto Com Stockholders | $1,400,723,000 | $1,020,951,000 | $897,556,000 | $779,437,000 |
| Tax Provision | $276,843,000 | $243,847,000 | $204,108,000 | $181,046,000 |
| Restructuring And Mergern Acquisition | $2,031,000 | $64,228,000 | $20,126,000 | $1,864,000 |
| Amortization | $45,273,000 | $46,521,000 | $42,020,000 | $31,078,000 |
| Research And Development | $331,284,000 | $307,525,000 | $287,642,000 | $253,575,000 |
| Selling General And Administration | $991,019,000 | $917,136,000 | $874,003,000 | $737,508,000 |
| Gain On Sale Of Security | - | $-4,045,000 | $9,922,000 | $-12,202,000 |
| Other Special Charges | - | - | $-20,227,000 | - |
Fetched: 2026-02-06
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $2,456,318,000 | $1,536,084,000 | $807,263,000 | $1,078,365,000 |
| Total Assets | $8,174,391,000 | $6,872,394,000 | $6,751,708,000 | $5,095,853,000 |
| Total Non Current Assets | $4,668,786,000 | $4,514,675,000 | $4,383,878,000 | $3,164,375,000 |
| Other Non Current Assets | $185,839,000 | $284,001,000 | $262,453,000 | $171,748,000 |
| Non Current Deferred Assets | $253,119,000 | $203,569,000 | $132,974,000 | $79,746,000 |
| Non Current Deferred Taxes Assets | $253,119,000 | $203,569,000 | $132,974,000 | $79,746,000 |
| Goodwill And Other Intangible Assets | $3,511,541,000 | $3,327,959,000 | $3,322,640,000 | $2,282,386,000 |
| Other Intangible Assets | $464,861,000 | $485,904,000 | $552,341,000 | $345,944,000 |
| Current Assets | $3,505,605,000 | $2,357,719,000 | $2,367,830,000 | $1,931,478,000 |
| Other Current Assets | $164,498,000 | $141,829,000 | $179,925,000 | $131,265,000 |
| Prepaid Assets | $213,279,000 | $279,821,000 | $257,093,000 | $206,643,000 |
| Inventory | $927,711,000 | $822,250,000 | $998,012,000 | $743,910,000 |
| Receivables | $990,667,000 | $875,458,000 | $704,909,000 | $575,950,000 |
| Other Receivables | $51,175,000 | $38,183,000 | - | - |
| Accounts Receivable | $939,492,000 | $837,275,000 | $704,909,000 | $575,950,000 |
| Allowance For Doubtful Accounts Receivable | $-22,424,000 | $-21,132,000 | $-23,603,000 | $-23,259,000 |
| Gross Accounts Receivable | $961,916,000 | $858,407,000 | $728,512,000 | $599,209,000 |
| Cash Cash Equivalents And Short Term Investments | $1,209,450,000 | $238,361,000 | $227,891,000 | $273,710,000 |
| Cash And Cash Equivalents | $1,209,450,000 | $238,361,000 | $227,891,000 | $273,710,000 |
| Non Current Prepaid Assets | - | - | - | $171,748,000 |
| Debt | ||||
| Total Debt | $851,813,000 | $873,935,000 | $1,579,908,000 | $917,550,000 |
| Long Term Debt And Capital Lease Obligation | $811,407,000 | $838,757,000 | $1,548,087,000 | $885,778,000 |
| Long Term Debt | $658,392,000 | $697,313,000 | $1,431,234,000 | $765,325,000 |
| Current Debt And Capital Lease Obligation | $40,406,000 | $35,178,000 | $31,821,000 | $31,772,000 |
| Current Debt | $9,900,000 | $9,900,000 | $9,902,000 | $9,916,000 |
| Other Current Borrowings | $9,900,000 | $9,900,000 | $9,902,000 | $9,916,000 |
| Net Debt | - | $468,852,000 | $1,213,245,000 | $501,531,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,206,532,000 | $2,008,351,000 | $2,621,805,000 | $1,735,102,000 |
| Total Non Current Liabilities Net Minority Interest | $1,187,412,000 | $1,097,696,000 | $1,863,272,000 | $1,045,803,000 |
| Other Non Current Liabilities | $141,520,000 | $42,257,000 | $68,166,000 | $5,974,000 |
| Tradeand Other Payables Non Current | $0 | $0 | $37,183,000 | $48,882,000 |
| Non Current Deferred Liabilities | $234,485,000 | $216,682,000 | $209,836,000 | $105,169,000 |
| Non Current Deferred Taxes Liabilities | $77,682,000 | $79,339,000 | $90,650,000 | $9,714,000 |
| Current Liabilities | $1,019,120,000 | $910,655,000 | $758,533,000 | $689,299,000 |
| Other Current Liabilities | $2,695,000 | $4,654,000 | $9,558,000 | $1,947,000 |
| Current Deferred Liabilities | $166,030,000 | $152,554,000 | $138,072,000 | $108,667,000 |
| Payables And Accrued Expenses | $809,989,000 | $718,269,000 | $579,082,000 | $546,913,000 |
| Interest Payable | $8,642,000 | $9,206,000 | $9,375,000 | $7,983,000 |
| Payables | $446,015,000 | $372,261,000 | $246,616,000 | $230,478,000 |
| Total Tax Payable | $167,858,000 | $134,533,000 | $95,860,000 | $71,233,000 |
| Income Tax Payable | $132,274,000 | $107,517,000 | $72,224,000 | $44,893,000 |
| Accounts Payable | $278,157,000 | $237,728,000 | $150,756,000 | $159,245,000 |
| Equity | ||||
| Common Stock Equity | $5,967,859,000 | $4,864,043,000 | $4,129,903,000 | $3,360,751,000 |
| Total Equity Gross Minority Interest | $5,967,859,000 | $4,864,043,000 | $4,129,903,000 | $3,360,751,000 |
| Stockholders Equity | $5,967,859,000 | $4,864,043,000 | $4,129,903,000 | $3,360,751,000 |
| Gains Losses Not Affecting Retained Earnings | $-74,699,000 | $-251,529,000 | $-272,528,000 | $-312,747,000 |
| Other Equity Adjustments | $-74,699,000 | $-251,529,000 | $-272,528,000 | $-312,747,000 |
| Retained Earnings | $6,081,490,000 | $4,991,647,000 | $4,253,016,000 | $3,613,736,000 |
| Other | ||||
| Treasury Shares Number | $43,925,747 | $42,664,067 | $41,836,234 | $41,836,234 |
| Ordinary Shares Number | $146,385,350 | $146,901,045 | $147,064,349 | $146,410,721 |
| Share Issued | $190,311,097 | $189,565,112 | $188,900,583 | $188,246,955 |
| Tangible Book Value | $2,456,318,000 | $1,536,084,000 | $807,263,000 | $1,078,365,000 |
| Invested Capital | $6,636,151,000 | $5,571,256,000 | $5,571,039,000 | $4,135,992,000 |
| Working Capital | $2,486,485,000 | $1,447,064,000 | $1,609,297,000 | $1,242,179,000 |
| Capital Lease Obligations | $183,521,000 | $166,722,000 | $138,772,000 | $142,309,000 |
| Total Capitalization | $6,626,251,000 | $5,561,356,000 | $5,561,137,000 | $4,126,076,000 |
| Treasury Stock | $2,073,292,000 | $1,773,267,000 | $1,623,256,000 | $1,623,256,000 |
| Additional Paid In Capital | $2,033,599,000 | $1,896,604,000 | $1,772,083,000 | $1,682,432,000 |
| Capital Stock | $761,000 | $588,000 | $588,000 | $586,000 |
| Common Stock | $761,000 | $588,000 | $588,000 | $586,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $156,803,000 | $137,343,000 | $119,186,000 | $95,455,000 |
| Long Term Capital Lease Obligation | $153,015,000 | $141,444,000 | $116,853,000 | $120,453,000 |
| Current Deferred Revenue | $166,030,000 | $152,554,000 | $138,072,000 | $108,667,000 |
| Current Capital Lease Obligation | $30,506,000 | $25,278,000 | $21,919,000 | $21,856,000 |
| Current Accrued Expenses | $363,974,000 | $346,008,000 | $332,466,000 | $316,435,000 |
| Goodwill | $3,046,680,000 | $2,842,055,000 | $2,770,299,000 | $1,936,442,000 |
| Net PPE | $718,287,000 | $699,146,000 | $665,811,000 | $630,495,000 |
| Accumulated Depreciation | $-705,308,000 | $-726,967,000 | $-668,012,000 | $-633,114,000 |
| Gross PPE | $1,423,595,000 | $1,426,113,000 | $1,333,823,000 | $1,263,609,000 |
| Leases | $124,046,000 | $102,104,000 | $91,499,000 | $80,855,000 |
| Other Properties | $288,622,000 | $278,479,000 | $243,651,000 | $237,754,000 |
| Machinery Furniture Equipment | $728,614,000 | $762,488,000 | $715,599,000 | $663,634,000 |
| Buildings And Improvements | $230,631,000 | $231,065,000 | $231,019,000 | $229,502,000 |
| Land And Improvements | $51,682,000 | $51,977,000 | $52,055,000 | $51,864,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $557,877,000 | $463,967,000 | $534,930,000 | $385,608,000 |
| Work In Process | $2,550,000 | $2,713,000 | $3,956,000 | $3,077,000 |
| Raw Materials | $367,284,000 | $355,570,000 | $459,126,000 | $355,225,000 |
Fetched: 2026-02-06
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,650,946,000 | $1,286,404,000 | $559,299,000 | $195,111,000 |
| Operating Activities | ||||
| Operating Cash Flow | $1,751,588,000 | $1,401,260,000 | $693,299,000 | $351,147,000 |
| Cash Flow From Continuing Operating Activities | $1,751,588,000 | $1,401,260,000 | $693,299,000 | $351,147,000 |
| Operating Gains Losses | $6,655,000 | $5,893,000 | $216,000 | $20,688,000 |
| Investing Activities | ||||
| Capital Expenditure | $-100,642,000 | $-114,856,000 | $-134,000,000 | $-156,036,000 |
| Investing Cash Flow | $-200,045,000 | $-269,784,000 | $-1,159,845,000 | $-229,918,000 |
| Cash Flow From Continuing Investing Activities | $-200,045,000 | $-269,784,000 | $-1,159,845,000 | $-229,918,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-300,025,000 | $-150,011,000 | $0 | $0 |
| Issuance Of Capital Stock | $74,439,000 | $53,094,000 | $49,142,000 | $47,384,000 |
| Financing Cash Flow | $-606,253,000 | $-1,119,287,000 | $422,874,000 | $-128,363,000 |
| Cash Flow From Continuing Financing Activities | $-606,253,000 | $-1,119,287,000 | $422,874,000 | $-128,363,000 |
| Net Other Financing Charges | $-29,787,000 | $-10,050,000 | $-32,992,000 | $-52,406,000 |
| Cash Dividends Paid | $-310,880,000 | $-282,320,000 | $-258,276,000 | $-245,341,000 |
| Common Stock Dividend Paid | $-310,880,000 | $-282,320,000 | $-258,276,000 | $-245,341,000 |
| Net Common Stock Issuance | $-225,586,000 | $-96,917,000 | $49,142,000 | $47,384,000 |
| Common Stock Issuance | $74,439,000 | $53,094,000 | $49,142,000 | $47,384,000 |
| Other | ||||
| Repayment Of Debt | $-40,000,000 | $-835,000,000 | $-405,000,000 | $-166,000,000 |
| Issuance Of Debt | $0 | $105,000,000 | $1,070,000,000 | $288,000,000 |
| Interest Paid Supplemental Data | $28,415,000 | $45,708,000 | $47,379,000 | $22,312,000 |
| Income Tax Paid Supplemental Data | $214,013,000 | $278,400,000 | $216,866,000 | $478,120,000 |
| End Cash Position | $1,209,450,000 | $238,361,000 | $227,891,000 | $273,710,000 |
| Beginning Cash Position | $238,361,000 | $227,891,000 | $273,710,000 | $295,278,000 |
| Effect Of Exchange Rate Changes | $25,799,000 | $-1,719,000 | $-2,147,000 | $-14,434,000 |
| Changes In Cash | $945,290,000 | $12,189,000 | $-43,672,000 | $-7,134,000 |
| Common Stock Payments | $-300,025,000 | $-150,011,000 | $0 | $0 |
| Net Issuance Payments Of Debt | $-40,000,000 | $-730,000,000 | $665,000,000 | $122,000,000 |
| Net Long Term Debt Issuance | $-40,000,000 | $-730,000,000 | $665,000,000 | $122,000,000 |
| Long Term Debt Payments | $-40,000,000 | $-835,000,000 | $-405,000,000 | $-166,000,000 |
| Long Term Debt Issuance | $0 | $105,000,000 | $1,070,000,000 | $288,000,000 |
| Net Investment Purchase And Sale | $39,845,000 | $-21,464,000 | $-13,096,000 | $-31,098,000 |
| Sale Of Investment | $46,261,000 | $1,000,000 | $19,133,000 | $6,802,000 |
| Purchase Of Investment | $-6,416,000 | $-22,464,000 | $-32,229,000 | $-37,900,000 |
| Net Business Purchase And Sale | $-139,248,000 | $-133,464,000 | $-1,012,749,000 | $-42,784,000 |
| Purchase Of Business | $-139,248,000 | $-133,464,000 | $-1,012,749,000 | $-42,784,000 |
| Net Intangibles Purchase And Sale | $-10,777,000 | $-15,396,000 | $-14,328,000 | $-21,201,000 |
| Purchase Of Intangibles | $-10,777,000 | $-15,396,000 | $-14,328,000 | $-21,201,000 |
| Net PPE Purchase And Sale | $-89,865,000 | $-99,460,000 | $-119,672,000 | $-134,835,000 |
| Purchase Of PPE | $-89,865,000 | $-99,460,000 | $-119,672,000 | $-134,835,000 |
| Change In Working Capital | $16,738,000 | $44,784,000 | $-462,127,000 | $-708,076,000 |
| Change In Payables And Accrued Expense | $90,958,000 | $122,072,000 | $31,342,000 | $-247,632,000 |
| Change In Prepaid Assets | $82,629,000 | $-115,213,000 | $-138,125,000 | $-168,109,000 |
| Change In Inventory | $-80,165,000 | $172,203,000 | $-248,833,000 | $-311,681,000 |
| Change In Receivables | $-76,684,000 | $-134,278,000 | $-106,511,000 | $19,346,000 |
| Changes In Account Receivables | $-76,684,000 | $-134,278,000 | $-106,511,000 | $19,346,000 |
| Stock Based Compensation | $91,661,000 | $80,184,000 | $71,142,000 | $65,257,000 |
| Depreciation Amortization Depletion | $235,811,000 | $216,209,000 | $197,562,000 | $193,841,000 |
| Depreciation And Amortization | $235,811,000 | $216,209,000 | $197,562,000 | $193,841,000 |
| Depreciation | $235,811,000 | $216,209,000 | $197,562,000 | $193,841,000 |
| Earnings Losses From Equity Investments | $6,655,000 | $5,893,000 | $216,000 | $20,688,000 |
| Net Income From Continuing Operations | $1,400,723,000 | $1,020,951,000 | $897,556,000 | $779,437,000 |
| Other Non Cash Items | - | $33,239,000 | $-11,050,000 | - |
| Gain Loss On Investment Securities | - | $4,045,000 | $-9,922,000 | $12,202,000 |
| Change In Payable | - | - | - | $-247,632,000 |
| Change In Account Payable | - | - | - | $-247,632,000 |
Fetched: 2026-02-06